How Is Agent Orange Exposure Actually Tested?

Testing for Agent Orange exposure centers on measuring a specific toxic contaminant, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), in a person’s blood. The standard laboratory method uses a technique called high-resolution gas chromatography paired with high-resolution mass spectrometry, which can detect TCDD at extraordinarily low concentrations in serum or plasma. But the story of testing is far more complicated than drawing blood and running a machine, because TCDD slowly leaves the body over years and decades, and most veterans and exposed civilians were not tested until long after their contact with the herbicide.

What Testers Are Actually Looking For

Agent Orange itself was a mixture of two herbicide chemicals used during the Vietnam War. The herbicides were not especially toxic on their own. The real health concern comes from TCDD, a dioxin that contaminated the mixture during manufacturing.¹ TCDD is one of the most toxic synthetic compounds ever studied. It binds tightly to fat in the body and is released very slowly, which is both what makes it dangerous and what makes it detectable years after exposure. When researchers or clinicians talk about “testing for Agent Orange exposure,” they almost always mean measuring how much TCDD is sitting in someone’s body fat or circulating in their blood lipids.

The Blood Test

The gold-standard test involves collecting a blood sample and running it through high-resolution gas chromatography combined with high-resolution mass spectrometry. This instrument separates the thousands of chemical compounds in a blood sample and then identifies specific molecules by their mass. For TCDD testing, roughly 50 milliliters of serum is needed, and the equipment can detect concentrations as low as about 0.3 to 0.4 parts per trillion on a lipid-weight basis.² That sensitivity is necessary because the amounts involved are vanishingly small. A “part per trillion” is roughly equivalent to one drop of water in an Olympic swimming pool.

This same analytical approach has been used in studies of American Vietnam veterans, where blood samples from veterans were analyzed alongside pooled semen samples using the same chromatography-mass spectrometry technique to look for dioxins, dibenzofurans, and related compounds.³ Vietnamese populations in formerly sprayed areas have also been tested, with researchers analyzing human milk, fat tissue, and blood for dioxins and related chemicals.⁴ More recent studies in Vietnam have followed EPA Method 1613, a standardized protocol that uses the same gas chromatography-mass spectrometry approach but with strict quality-control steps, to measure TCDD in blood plasma.⁵

Why Blood Replaced Fat Biopsies

Because TCDD dissolves in fat, early testing efforts sometimes collected adipose (fat) tissue through biopsies. That made physiological sense but was painful and invasive for the person being tested. A key finding from a study of Agent Orange-exposed Vietnam veterans and matched controls changed this. Researchers found a very strong correlation between TCDD levels in blood and TCDD levels in fat tissue, suggesting the two compartments stay in a kind of moving equilibrium.⁶ A separate study of Massachusetts veterans confirmed the finding, showing that TCDD levels in blood and fat were similar when measured on a lipid basis.⁷ This meant a simple blood draw could provide essentially the same information as a surgical biopsy, making large-scale testing of veteran populations far more practical.

The Half-Life Problem

Here is where testing gets genuinely difficult. TCDD does not stay in the body forever. It slowly breaks down and is eliminated, and the rate at which this happens depends on a person’s age and how much TCDD they were carrying to begin with. In adults, the average elimination half-life is roughly three years, meaning that every three years or so, about half the remaining TCDD disappears from the body. In children and adolescents, the half-life is shorter, averaging about a year and a half, and it appears to increase by roughly a tenth of a year for each year of age.⁸ Higher body burdens are also cleared somewhat faster.

For a veteran who was sprayed in 1968 and tested in 1990, more than two decades of elimination had occurred. Depending on their original exposure level, their blood TCDD concentration by then might have been only a fraction of what it was during service. This is exactly what showed up in a large study of Korean Vietnam veterans tested decades after their deployments. The average serum TCDD level across the group was only about 1.2 parts per trillion, and just two veterans out of the entire study population had levels above 10 parts per trillion. Critically, the measured TCDD levels did not track with how close the veterans had been to spraying zones or how much exposure they believed they had experienced.⁹ The levels were not significantly different based on military unit, deployment year, time in Vietnam, rank, age, body mass, or smoking status. The most likely explanation is not that these veterans were never exposed but that TCDD had simply washed out over the intervening decades.

This half-life problem is the fundamental limitation of blood testing for Agent Orange exposure. The test works well if it is done soon after exposure, but it loses reliability with every passing year. By the time most epidemiological studies were launched, the biological clock had already ticked down much of the evidence.

Reconstructing Exposure from Military Records

Because blood tests taken decades later often cannot distinguish exposed from unexposed veterans, researchers developed a different strategy: reconstructing where a person was and where herbicides were sprayed, then inferring whether they overlapped. This approach relies heavily on historical military records rather than any biological sample.

A geographic information system (GIS) was built specifically for this purpose, integrating several data layers: the HERBS records documenting Ranch Hand aircraft flight paths, how many gallons were sprayed and which chemical agent was used, the locations of military bases and units, the movement of combat troops across Vietnam, and the positions of civilian population centers.¹⁰ By overlaying a veteran’s service history on the spraying data, researchers could estimate what is called “exposure opportunity,” essentially a probability estimate of whether a given person was in the right place at the right time to have been exposed.

Exposure opportunity models were developed to go further, producing quantitative estimates that could be plugged into epidemiological studies. These models use the GIS framework to reconstruct a person’s location history and compare it with the spraying history for each area they passed through.¹¹ A parallel effort focused specifically on ground troops, using contemporary military records to characterize potential exposure when serum dioxin levels measured long after service were uncertain.¹²

The strength of this approach is that it does not depend on a chemical still being in someone’s body. The weakness is that military records are incomplete. Troop movement logs are not always precise, soldiers sometimes went to areas not recorded in official records, and the herbicide spraying data itself has gaps. Still, for veterans tested too late for blood TCDD to be informative, historical reconstruction is often the best available tool.

Clinical Signs That Suggest Exposure

Some physical findings can point toward dioxin exposure even without a blood test. The most recognized is chloracne, a distinctive skin condition that looks superficially like severe acne but is mechanistically different. Chloracne is considered one of the most specific and sensitive clinical markers of TCDD exposure and has been used in both clinical and epidemiological settings to estimate who was exposed and at roughly what dose.¹³

The lesions typically appear on the face within weeks of significant dioxin intake and then spread to the trunk and limbs. What happens at the cellular level is that TCDD disrupts the normal replacement cycle in sebaceous glands, causing abnormal tissue growths to develop where functional oil-producing cells should be.¹⁴ If a veteran or exposed civilian developed chloracne during or shortly after potential exposure, that is fairly strong evidence of significant TCDD contact, independent of any laboratory test. The catch is that chloracne can fade over time in some people and may not develop at lower doses, so its absence does not rule out exposure.

Another clinical marker involves porphyrins, a group of molecules the body uses to build heme (the oxygen-carrying part of hemoglobin). Toxic chemical exposures, including dioxins, can disrupt heme production and cause abnormal porphyrin patterns in blood, urine, or stool. Tests for porphyria have been increasingly included in evaluations of people with known chemical exposures.¹⁵ Like chloracne, abnormal porphyrin profiles are suggestive but not perfectly specific to dioxin; other chemical exposures can cause similar disruptions.

Testing the Environment, Not the Person

A parallel testing effort has focused on measuring TCDD in soil, sediment, and food near former spray zones in Vietnam. This does not directly tell you whether a specific person was exposed, but it helps establish whether exposure pathways still exist in communities that live on contaminated land. Environmental testing uses similar analytical chemistry to blood testing, but the sample preparation is different and the concentrations involved can be orders of magnitude higher, particularly near former military airbases where herbicide stocks were stored or spilled.

Traditional sampling methods, where you dig up a few scoops of dirt and test each one separately, turned out to underestimate how much contamination was actually present. TCDD distribution in soil is extremely patchy; a sample from one spot might read clean while a sample a few meters away might be heavily contaminated. A newer approach called Incremental Sampling Methodology (ISM) was developed to deal with this. Instead of testing individual scoops, ISM collects dozens of small increments across an area and combines them into a single sample, giving a much more reliable estimate of the true average contamination. At a former Vietnamese airbase, ISM reduced variability between samples from the same area by about two-thirds and increased the frequency that cleanup boundaries actually met project goals by over 60 percent compared with traditional sampling.¹⁶

Bioassay Screening

Not every laboratory has access to the expensive mass spectrometry equipment needed for the gold-standard TCDD test. Bioassay methods offer a cheaper screening alternative. The most widely used is called CALUX, a cell-based assay in which genetically engineered cells light up when they detect chemicals that activate a specific receptor (the aryl hydrocarbon receptor, or AhR) that TCDD targets. Researchers have used CALUX to assess dioxin-like contamination in Vietnamese soil samples, including areas around a former airbase in Thua Thien Hue province.¹⁷

CALUX is valuable for screening large numbers of samples quickly, but it has a built-in limitation: the assay responds to all chemicals that activate the AhR receptor, not just TCDD. That means complex mixtures in real-world environmental or biological samples can produce responses that are hard to interpret. Antagonistic or synergistic interactions between different AhR-activating chemicals can push the reading up or down in ways that do not reflect the actual TCDD concentration alone.¹⁸ For definitive confirmation, samples that flag positive on CALUX still need to be run through full mass spectrometry.

Epigenetic Markers and Newer Molecular Approaches

Because TCDD itself eventually disappears from the body, researchers have started looking for molecular footprints that TCDD might leave behind even after the chemical is gone. The most active area involves DNA methylation, a process where small chemical tags are added to or removed from DNA, altering how genes behave without changing the genetic code itself. The idea is that TCDD exposure might leave a distinctive methylation signature that persists long after the dioxin has been eliminated.

A pilot study of Operation Ranch Hand veterans (the Air Force unit that carried out the spraying missions) looked at methylation patterns in both fat tissue and blood. While the study did not find any methylation changes that cleared the strict statistical threshold for genome-wide significance, a handful of sites in both tissues showed suggestive changes linked to higher TCDD burden.¹⁹ The findings were preliminary, and the study was small, but they point toward the possibility that a methylation-based test could someday supplement or even replace blood TCDD measurement.

A study of Korean Vietnam veterans went further, identifying seven specific methylation sites associated with both Agent Orange exposure and the development of type 2 diabetes. The researchers used a statistical technique to test whether these methylation changes were part of the causal chain linking Agent Orange exposure to diabetes, and found evidence that they were.²⁰ If this kind of work is replicated and expanded, epigenetic profiles could eventually serve as a biological record of past TCDD exposure that persists long after the dioxin itself has been cleared from the body. That would be transformative for veterans and exposed civilians who were never tested during or shortly after the war.

What Testing Means for Benefits and Compensation

For many veterans, the question of how Agent Orange exposure is tested is not academic; it determines whether they qualify for disability benefits. In practice, the U.S. Department of Veterans Affairs does not typically require a blood TCDD test to grant a service-connected disability for conditions on the VA’s presumptive list. Instead, the VA recognizes that veterans who served in certain locations during certain time periods were presumptively exposed. If you served boots-on-the-ground in Vietnam during the war, or at specific bases in Thailand, or handled Agent Orange during testing or transport, the VA presumes you were exposed and evaluates your claim based on your diagnosis rather than a lab result.

This presumptive approach exists precisely because of the testing limitations outlined above. A blood test taken 40 or 50 years after exposure is unlikely to show elevated TCDD, so requiring one as proof would unfairly deny benefits to veterans who were genuinely exposed. The list of presumptive conditions has expanded over the years and now includes several cancers, type 2 diabetes, ischemic heart disease, and other diseases. A meta-analysis of studies on birth defects and Agent Orange found that the strength of association tended to increase with greater estimated exposure, supporting a dose-response relationship even when individual TCDD measurements were ambiguous.²¹

Genetic Variation in How People Process TCDD

An emerging layer of complexity is that people differ in how efficiently their bodies process and clear dioxins. A 2024 study examined variants in a gene called UGT1A1, which codes for an enzyme involved in breaking down various toxic compounds. Researchers measured TCDD in the blood of 100 people exposed to Agent Orange in Vietnam and simultaneously analyzed their UGT1A1 gene variants, enzyme levels, and gene expression using a combination of DNA sequencing, ELISA protein measurement, and gene-expression testing.⁵ The implication is that two people with identical initial exposure might show very different TCDD levels years later, not because one was exposed less but because their bodies cleared the chemical at different rates. This kind of genetic variability adds another wrinkle to the already-difficult task of interpreting a TCDD blood level measured decades after the fact.

For anyone trying to make sense of a TCDD result, this means the number on the lab report does not translate straightforwardly to “how much Agent Orange you were exposed to.” A low number might mean low exposure, or it might mean efficient elimination over many years. A high number almost certainly indicates meaningful exposure, but exactly how much and when remains uncertain. The combination of time, individual biology, and the limits of historical records makes Agent Orange exposure testing less a single definitive test and more a mosaic of evidence, each piece imperfect on its own but collectively painting a more complete picture.